Opis działalności
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
Zarząd & Rada nadzorcza
| CEO |
| Daniel O’Day |
| Zarząd |
| Andrew Dickinson, Jyoti Mehra, Stacey Ma, Flavius Martin, Johanna Mercier, Cindy Perettie, Deborah H. Telman, Merdad Parsey |
| Rada nadzorcza |
| Daniel O’Day, Jacqueline K. Barton, Jeffrey A. Bluestone, Sandra J. Horning, Kelly A. Kramer, Harish Manwani, Anthony Welters, Ted W. Love, Javier J. Rodriguez |
Dane firmy
| Nazwa: |
Gilead Sciences Inc. |
| Adres: |
333 Lakeside Drive,Foster City, California 94404, USA |
| Telefon: |
+1-650-574-3000 |
| Fax: |
+1-650-578-9264 |
| E-mail: |
corporate_developmen...ad.com
corporate_development@gilead.com
|
| Internet: |
www.gilead.com |
| Przemysł: |
Służba zdrowia |
| Sektor: |
Przemysł Farmaceutyczny |
| Podsektor: |
Przemysł Farmaceutyczny |
| Koniec roku finansowego: |
31.12 |
| Free float: |
55,84% |
| Data IPO: |
22.01.1992 |
